首页 > 最新文献

Current Urology Reports最新文献

英文 中文
Advancements in Surgical Management of Megaureters. 巨尿道手术治疗的进展。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 Epub Date: 2024-07-02 DOI: 10.1007/s11934-024-01214-8
Timothy C Boswell

Purpose of review: To review and describe the recent evolution of surgery for the various types of pediatric megaureter.

Recent findings: Megaureter management first relies on determining the underlying cause, whether by obstruction, reflux, or a combination, and then setting appropriate surgical indications because many cases do not require surgery as shown by observation studies. Endoscopic balloon dilation has been on the rise as a major treatment option for obstructive megaureter, while refluxing megaureters can also be treated by laparoscopic and robotic techniques, whether extravesically or transvesicoscopically. During ureteral reimplantation, tapering is sometimes necessary to address the enlarged ureter, but there are also considerations for not tapering or for tapering alternatives. Endoscopic and minimally invasive surgeries for megaureter have been the predominant focus of recent megaureter literature. These techniques still need collaborative prospective studies to better define which surgeries are best for patients needing megaureter interventions.

综述目的回顾和描述各种类型小儿巨输尿管手术的最新进展:巨输尿管的治疗首先要确定根本原因,是梗阻、反流还是综合原因,然后再确定适当的手术指征,因为观察研究表明,许多病例并不需要手术。内镜下球囊扩张术已成为治疗梗阻性巨输尿管的主要方法,而反流性巨输尿管也可通过腹腔镜和机器人技术(无论是膀胱外镜还是经膀胱镜)进行治疗。在输尿管再植术中,有时需要进行锥切以解决输尿管扩大的问题,但也有不锥切或替代锥切的考虑因素。内窥镜和微创手术治疗巨型输尿管是近期巨型输尿管文献的主要焦点。这些技术仍然需要前瞻性的合作研究,以更好地确定哪种手术最适合需要巨输尿管介入治疗的患者。
{"title":"Advancements in Surgical Management of Megaureters.","authors":"Timothy C Boswell","doi":"10.1007/s11934-024-01214-8","DOIUrl":"10.1007/s11934-024-01214-8","url":null,"abstract":"<p><strong>Purpose of review: </strong>To review and describe the recent evolution of surgery for the various types of pediatric megaureter.</p><p><strong>Recent findings: </strong>Megaureter management first relies on determining the underlying cause, whether by obstruction, reflux, or a combination, and then setting appropriate surgical indications because many cases do not require surgery as shown by observation studies. Endoscopic balloon dilation has been on the rise as a major treatment option for obstructive megaureter, while refluxing megaureters can also be treated by laparoscopic and robotic techniques, whether extravesically or transvesicoscopically. During ureteral reimplantation, tapering is sometimes necessary to address the enlarged ureter, but there are also considerations for not tapering or for tapering alternatives. Endoscopic and minimally invasive surgeries for megaureter have been the predominant focus of recent megaureter literature. These techniques still need collaborative prospective studies to better define which surgeries are best for patients needing megaureter interventions.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"215-223"},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11306539/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Genetic Testing in Kidney Stone Disease: A Narrative Review 基因检测在肾结石病中的作用:叙述性综述
IF 2.6 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-08-03 DOI: 10.1007/s11934-024-01225-5
Robert Geraghty, Catherine Lovegrove, Sarah Howles, John A. Sayer

Purpose of Review

Kidney stone disease (KSD) is a common and potentially life-threatening condition, and half of patients experience a repeat kidney stone episode within 5–10 years. Despite the ~50% estimate heritability of KSD, international guidelines have not kept up with the pace of discovery of genetic causes of KSD. The European Association of Urology guidelines lists 7 genetic causes of KSD as ‘high risk’.

Recent Findings

There are currently 46 known monogenic (single gene) causes of kidney stone disease, with evidence of association in a further 23 genes. There is also evidence for polygenic risk of developing KSD. Evidence is lacking for recurrent disease, and only one genome wide association study has investigated this phenomenon, identifying two associated genes (SLC34A1 and TRPV5). However, in the absence of other evidence, patients with genetic predisposition to KSD should be treated as ‘high risk’. Further studies are needed to characterize both monogenic and polygenic associations with recurrent disease, to allow for appropriate risk stratification. Durability of test result must be balanced against cost. This would enable retrospective analysis if no genetic cause was found initially.

Summary

We recommend genetic testing using a gene panel for all children, adults < 25 years, and older patients who have factors associated with high risk disease within the context of a wider metabolic evaluation. Those with a genetic predisposition should be managed via a multi-disciplinary team approach including urologists, radiologists, nephrologists, clinical geneticists and chemical pathologists. This will enable appropriate follow-up, counselling and potentially prophylaxis.

综述目的肾结石病(KSD)是一种常见且可能危及生命的疾病,半数患者在 5-10 年内会再次发生肾结石。尽管 KSD 的遗传率估计约为 50%,但国际指南并未跟上发现 KSD 遗传病因的步伐。欧洲泌尿学协会指南将 7 种 KSD 遗传病因列为 "高风险"。还有证据表明,KSD 的发病风险是多基因的。目前还缺乏复发性疾病的证据,只有一项全基因组关联研究对这一现象进行了调查,发现了两个相关基因(SLC34A1 和 TRPV5)。然而,在缺乏其他证据的情况下,有 KSD 遗传倾向的患者应被视为 "高危 "患者。需要进一步研究单基因和多基因与复发性疾病的关系,以便进行适当的风险分层。检测结果的持久性必须与成本相平衡。小结我们建议在进行更广泛的代谢评估时,对所有儿童、25 岁的成年人和有高风险疾病相关因素的老年患者进行基因检测。对于有遗传倾向的患者,应通过多学科团队的方法进行管理,包括泌尿科医生、放射科医生、肾科医生、临床遗传学家和化学病理学家。这样才能进行适当的随访、咨询和潜在的预防。
{"title":"Role of Genetic Testing in Kidney Stone Disease: A Narrative Review","authors":"Robert Geraghty, Catherine Lovegrove, Sarah Howles, John A. Sayer","doi":"10.1007/s11934-024-01225-5","DOIUrl":"https://doi.org/10.1007/s11934-024-01225-5","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>Kidney stone disease (KSD) is a common and potentially life-threatening condition, and half of patients experience a repeat kidney stone episode within 5–10 years. Despite the ~50% estimate heritability of KSD, international guidelines have not kept up with the pace of discovery of genetic causes of KSD. The European Association of Urology guidelines lists 7 genetic causes of KSD as ‘high risk’.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>There are currently 46 known monogenic (single gene) causes of kidney stone disease, with evidence of association in a further 23 genes. There is also evidence for polygenic risk of developing KSD. Evidence is lacking for recurrent disease, and only one genome wide association study has investigated this phenomenon, identifying two associated genes (<i>SLC34A1</i> and <i>TRPV5</i>). However, in the absence of other evidence, patients with genetic predisposition to KSD should be treated as ‘high risk’. Further studies are needed to characterize both monogenic and polygenic associations with recurrent disease, to allow for appropriate risk stratification. Durability of test result must be balanced against cost. This would enable retrospective analysis if no genetic cause was found initially.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>We recommend genetic testing using a gene panel for all children, adults &lt; 25 years, and older patients who have factors associated with high risk disease within the context of a wider metabolic evaluation. Those with a genetic predisposition should be managed via a multi-disciplinary team approach including urologists, radiologists, nephrologists, clinical geneticists and chemical pathologists. This will enable appropriate follow-up, counselling and potentially prophylaxis.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"15 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141881735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plastic Clamp Versus Conventional Surgical Dissection Technique in Pediatric Circumcision: A Systematic Review and Meta-Analysis. 小儿包皮环切术中的塑料夹钳与传统手术剥离技术:系统综述与元分析》。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-08-01 Epub Date: 2024-05-21 DOI: 10.1007/s11934-024-01209-5
Xianming Yao, Gang Zhang, Qianwei Xiong, Shaoguang Feng, Xian Liu

Purpose: Phimosis is a common condition of the urinary system in children and often requires surgical treatment. However, the optimal method of circumcision for children has not been determined. We conducted a systematic review and meta-analysis to compare the safety and effectiveness of plastic clamp with conventional surgical circumcision in pediatric circumcision.

Methods: A literature search was carried out to compare the plastic clamp and conventional dissection technique in the pediatric population. The following search terms were used: "circumcision", "plastic clamp", "conventional", "plastibell", "children" and etc. Meta-analysis was used to pool and evaluate variables such as operative time, blood loss, wound infection, bleeding, edema, and total postoperative complications.

Results: The plastic clamp technique (PCT) was used in 10,412 of the 17,325 participants in the nine studies, while the conventional surgical dissection technique (CST) was used on 6913 patients. When compared to the CST approach, the PCT approach resulted in shorter operative times (mean difference (MD) -17.48, 95% CI -22 to -12.96; P < 0.001), less blood loss (MD -4.25, 95% CI -7.75 to -0.77; P = 0.02), and a higher incidence of postoperative edema (OR 2.33, 95% CI 1.34 to 4.08; P = 0.003). However, no significant difference was found in the incidence of postoperative complications, including wound infection and bleeding between PCT and CST.

Conclusions: PCT is a safe and time-saving option in the pediatric population. However, this method appeared to have a significant greater rate of postoperative edema.

目的:包皮过长是儿童泌尿系统的常见疾病,通常需要手术治疗。然而,儿童包皮环切术的最佳方法尚未确定。我们进行了一项系统性回顾和荟萃分析,以比较包皮环切整形术与传统外科包皮环切术的安全性和有效性:方法:我们进行了文献检索,以比较塑形钳和传统剖腹技术在儿科人群中的应用。搜索关键词如下"包皮环切术"、"塑形钳"、"传统"、"塑形钳"、"儿童 "等。采用 Meta 分析法对手术时间、失血量、伤口感染、出血、水肿和术后总并发症等变量进行汇总和评估:在九项研究的 17325 名参与者中,10412 名患者采用了塑形钳技术(PCT),而 6913 名患者采用了传统手术剥离技术(CST)。与 CST 方法相比,PCT 方法的手术时间更短(平均差 (MD) -17.48,95% CI -22 至 -12.96;P 结论:PCT 是一种安全、省时的手术方法:在儿科人群中,PCT 是一种安全、省时的选择。但是,这种方法的术后水肿率明显更高。
{"title":"Plastic Clamp Versus Conventional Surgical Dissection Technique in Pediatric Circumcision: A Systematic Review and Meta-Analysis.","authors":"Xianming Yao, Gang Zhang, Qianwei Xiong, Shaoguang Feng, Xian Liu","doi":"10.1007/s11934-024-01209-5","DOIUrl":"10.1007/s11934-024-01209-5","url":null,"abstract":"<p><strong>Purpose: </strong>Phimosis is a common condition of the urinary system in children and often requires surgical treatment. However, the optimal method of circumcision for children has not been determined. We conducted a systematic review and meta-analysis to compare the safety and effectiveness of plastic clamp with conventional surgical circumcision in pediatric circumcision.</p><p><strong>Methods: </strong>A literature search was carried out to compare the plastic clamp and conventional dissection technique in the pediatric population. The following search terms were used: \"circumcision\", \"plastic clamp\", \"conventional\", \"plastibell\", \"children\" and etc. Meta-analysis was used to pool and evaluate variables such as operative time, blood loss, wound infection, bleeding, edema, and total postoperative complications.</p><p><strong>Results: </strong>The plastic clamp technique (PCT) was used in 10,412 of the 17,325 participants in the nine studies, while the conventional surgical dissection technique (CST) was used on 6913 patients. When compared to the CST approach, the PCT approach resulted in shorter operative times (mean difference (MD) -17.48, 95% CI -22 to -12.96; P < 0.001), less blood loss (MD -4.25, 95% CI -7.75 to -0.77; P = 0.02), and a higher incidence of postoperative edema (OR 2.33, 95% CI 1.34 to 4.08; P = 0.003). However, no significant difference was found in the incidence of postoperative complications, including wound infection and bleeding between PCT and CST.</p><p><strong>Conclusions: </strong>PCT is a safe and time-saving option in the pediatric population. However, this method appeared to have a significant greater rate of postoperative edema.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"173-180"},"PeriodicalIF":2.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141070226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer. 放射治疗治疗局部和转移性前列腺癌概述。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-08-01 Epub Date: 2024-06-11 DOI: 10.1007/s11934-024-01217-5
Malcolm D Mattes

Purpose of review: The goal is to describe the evolution of radiation therapy (RT) utilization in the management of localized and metastatic prostate cancer.

Recent findings: Long term data for a variety of hypofractionated definitive RT dose-fractionation schemes has matured, allowing patients and providers many standard-of-care options to choose from. Post-prostatectomy, adjuvant RT has largely been replaced by an early salvage approach. Multiparametric MRI and PSMA PET have enabled increasingly targeted RT delivery to the prostate and oligometastatic tumors. Areas of active investigation include determining the value of proton beam therapy and perirectal spacers, and optimally incorporate genomic tumor profiling and next generation hormonal therapies with RT in the curative setting. The use of radiation therapy to treat prostate cancer is rapidly evolving. In the coming years, there will be continued improvements in a variety of areas to enhance the value of RT in multidisciplinary prostate cancer management.

综述的目的:目的是描述放射治疗(RT)在局部和转移性前列腺癌治疗中的应用演变:最近的研究结果:各种低分次确定性 RT 剂量分次方案的长期数据已经成熟,使患者和医疗服务提供者有了许多标准治疗方案可供选择。前列腺切除术后的辅助 RT 已在很大程度上被早期抢救方法所取代。多参数磁共振成像(MRI)和PSMA正电子发射计算机断层显像(PET)使前列腺和少转移肿瘤的RT治疗越来越有针对性。目前正在积极研究的领域包括确定质子束疗法和直肠周围间隔物的价值,以及在治愈性治疗中将肿瘤基因组分析和新一代激素疗法与 RT 最佳结合。利用放射疗法治疗前列腺癌的技术正在迅速发展。在未来几年中,各个领域都将不断改进,以提高 RT 在多学科前列腺癌治疗中的价值。
{"title":"Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer.","authors":"Malcolm D Mattes","doi":"10.1007/s11934-024-01217-5","DOIUrl":"10.1007/s11934-024-01217-5","url":null,"abstract":"<p><strong>Purpose of review: </strong>The goal is to describe the evolution of radiation therapy (RT) utilization in the management of localized and metastatic prostate cancer.</p><p><strong>Recent findings: </strong>Long term data for a variety of hypofractionated definitive RT dose-fractionation schemes has matured, allowing patients and providers many standard-of-care options to choose from. Post-prostatectomy, adjuvant RT has largely been replaced by an early salvage approach. Multiparametric MRI and PSMA PET have enabled increasingly targeted RT delivery to the prostate and oligometastatic tumors. Areas of active investigation include determining the value of proton beam therapy and perirectal spacers, and optimally incorporate genomic tumor profiling and next generation hormonal therapies with RT in the curative setting. The use of radiation therapy to treat prostate cancer is rapidly evolving. In the coming years, there will be continued improvements in a variety of areas to enhance the value of RT in multidisciplinary prostate cancer management.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"181-192"},"PeriodicalIF":2.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital Rectal Exam in Prostate Cancer Screening and Elevated PSA Work-up-Is there a role anymore? 前列腺癌筛查和 PSA 升高检查中的数字直肠检查--还有作用吗?
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-08-01 Epub Date: 2024-06-13 DOI: 10.1007/s11934-024-01218-4
Lane Shish, Joseph Zabell

Purpose of review: Prostate cancer (PCa) screening tools, particularly digital rectal examination (DRE), are under scrutiny. This review assesses the utility of DRE in PCa screening.

Recent findings: Recent studies reaffirm the DRE's sensitivity and specificity, a higher PCa detection rate with PSA in conjunction with DRE, and a slightly elevated risk of clinically significant PCa (CSPC) in those with elevated PSA and suspicious DRE. Studies confirm high accuracy of MRI in identifying CSPC, with ongoing research exploring its screening potential. DRE alone lacks accuracy for PCa screening, often resulting in missed diagnoses and unnecessary biopsies. Its supplementary use with PSA marginally increases detection rates of identifying a small percentage of CSPC, but the benefit remains questionable. Emerging evidence suggests MRI has the potential as a superior screening tool compared to DRE, although direct comparative studies are lacking. Overall, the DRE has a limited role in current PCa screening.

审查目的:前列腺癌(PCa)筛查工具,尤其是数字直肠检查(DRE),正受到严格审查。本综述评估了 DRE 在 PCa 筛查中的实用性:最新研究结果:最新研究再次证实了 DRE 的灵敏度和特异性,结合 DRE 的 PSA PCa 检出率更高,而 PSA 升高和 DRE 可疑者患临床意义 PCa(CSPC)的风险略有升高。研究证实,MRI 识别 CSPC 的准确率很高,目前正在对其筛查潜力进行研究。仅靠 DRE 无法准确筛查 PCa,常常导致漏诊和不必要的活检。它与 PSA 的辅助使用可略微提高一小部分 CSPC 的检出率,但其益处仍值得怀疑。新的证据表明,磁共振成像有可能成为比 DRE 更优越的筛查工具,但目前还缺乏直接的比较研究。总体而言,DRE 在当前 PCa 筛查中的作用有限。
{"title":"Digital Rectal Exam in Prostate Cancer Screening and Elevated PSA Work-up-Is there a role anymore?","authors":"Lane Shish, Joseph Zabell","doi":"10.1007/s11934-024-01218-4","DOIUrl":"10.1007/s11934-024-01218-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>Prostate cancer (PCa) screening tools, particularly digital rectal examination (DRE), are under scrutiny. This review assesses the utility of DRE in PCa screening.</p><p><strong>Recent findings: </strong>Recent studies reaffirm the DRE's sensitivity and specificity, a higher PCa detection rate with PSA in conjunction with DRE, and a slightly elevated risk of clinically significant PCa (CSPC) in those with elevated PSA and suspicious DRE. Studies confirm high accuracy of MRI in identifying CSPC, with ongoing research exploring its screening potential. DRE alone lacks accuracy for PCa screening, often resulting in missed diagnoses and unnecessary biopsies. Its supplementary use with PSA marginally increases detection rates of identifying a small percentage of CSPC, but the benefit remains questionable. Emerging evidence suggests MRI has the potential as a superior screening tool compared to DRE, although direct comparative studies are lacking. Overall, the DRE has a limited role in current PCa screening.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"193-199"},"PeriodicalIF":2.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparing Trainees to Rebound from Surgical Complications. 让受训人员做好从手术并发症中反弹的准备。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-08-01 Epub Date: 2024-05-26 DOI: 10.1007/s11934-024-01207-7
Lan Anh S Galloway, Amy N Luckenbaugh

Purpose of review: In this review, we aim to summarize the impact of surgical complications and adverse events on surgeons, including psychiatric illnesses. We evaluate current programs to develop trainee well-being and investigate research within the field of urology.

Recent findings: Surgical complications and adverse events affect all surgeons, including surgical trainees. Research estimates that 80% of healthcare professionals have been involved in an event that affected them emotionally. These events can affect physicians in many ways, ranging from negatively impacting their quality of life to leading to psychiatric disorders such as acute stress reactions and post-traumatic stress disorder. Unfortunately, there is no standardized preparation to equip trainees to manage and rebound from the profound emotional impact of surgical complications. Data in this realm is insufficient, especially in urology, and we need more research in order to better evaluate emotional implications of complications on trainees and how we can prepare trainees to handle them.

综述的目的:在这篇综述中,我们旨在总结手术并发症和不良事件对外科医生的影响,包括精神疾病。我们评估了当前培养受训人员健康的计划,并调查了泌尿外科领域内的研究:手术并发症和不良事件影响着所有外科医生,包括外科学员。据研究估计,80% 的医护人员都曾经历过影响其情绪的事件。这些事件会在很多方面对医生造成影响,从对他们的生活质量造成负面影响到导致精神障碍,如急性应激反应和创伤后应激障碍。遗憾的是,目前还没有标准化的准备工作来帮助受训者应对手术并发症所带来的深刻情绪影响,并从这种影响中恢复过来。这方面的数据不足,尤其是在泌尿外科,我们需要更多的研究,以便更好地评估并发症对受训者情绪的影响,以及如何让受训者做好应对并发症的准备。
{"title":"Preparing Trainees to Rebound from Surgical Complications.","authors":"Lan Anh S Galloway, Amy N Luckenbaugh","doi":"10.1007/s11934-024-01207-7","DOIUrl":"10.1007/s11934-024-01207-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>In this review, we aim to summarize the impact of surgical complications and adverse events on surgeons, including psychiatric illnesses. We evaluate current programs to develop trainee well-being and investigate research within the field of urology.</p><p><strong>Recent findings: </strong>Surgical complications and adverse events affect all surgeons, including surgical trainees. Research estimates that 80% of healthcare professionals have been involved in an event that affected them emotionally. These events can affect physicians in many ways, ranging from negatively impacting their quality of life to leading to psychiatric disorders such as acute stress reactions and post-traumatic stress disorder. Unfortunately, there is no standardized preparation to equip trainees to manage and rebound from the profound emotional impact of surgical complications. Data in this realm is insufficient, especially in urology, and we need more research in order to better evaluate emotional implications of complications on trainees and how we can prepare trainees to handle them.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"169-172"},"PeriodicalIF":2.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141154977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fertility Preservation in Children and Adolescents: Where We Are and Where We Are Going. 儿童和青少年的生育能力保护:我们的现状与未来。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 Epub Date: 2024-05-10 DOI: 10.1007/s11934-024-01204-w
Campbell Vogt, Neha R Malhotra

Purpose of review: This review will describe current pediatric and adolescent fertility preservation methodologies and the ethical concerns surrounding these procedures, as well as highlight recent research that may pave the way for the development of new fertility preservation options.

Recent findings: Research is ongoing to allow prepubertal patients, particularly those with testes, to be able to have biologic children in the future. Studies on sperm in vitro maturation highlight the importance of supporting the spermatogonial stem cell niche for the development of mature sperm. The live birth of a rhesus macaque from in vitro fertilization using prepubertal testicular tissue and in vivo matured sperm gives hope to future human births. For patients with ovaries, prior work has led to successful fertility but further research is underway to refine these techniques and optimize outcomes. Organoid scaffolds have shown promise when being used for in vitro oocyte maturation. For children and adolescents undergoing gonadotoxic treatment, such as chemotherapy, or hormonal treatment, such as gender-affirming hormone therapy, future fertility potential may be negatively impacted. It is recommended that fertility preservation (FP) be offered to these patients and families prior to undergoing treatment. Fertility preservation for postpubertal patients mimics that in adults. For prepubertal children, however, the options are limited and in some cases still experimental. It is essential that this work continues so that we may offer children and adolescents the right to an open future and preserve their fertility potential.

综述的目的:本综述将介绍目前的儿科和青少年生育力保存方法和围绕这些程序的伦理问题,并重点介绍可能为开发新的生育力保存方案铺平道路的最新研究:为了让青春期前的患者,尤其是有睾丸的患者,将来能生育亲生子女,相关研究正在进行中。对精子体外成熟的研究强调了支持精原干细胞龛位对发育成熟精子的重要性。利用青春期前的睾丸组织和体内成熟的精子进行体外受精,成功使一只猕猴活产,这给未来人类生育带来了希望。对于有卵巢的患者来说,之前的工作已使他们成功生育,但目前仍在进行进一步的研究,以完善这些技术并优化结果。类器官支架在用于体外卵母细胞成熟时已显示出前景。对于正在接受性腺毒性治疗(如化疗)或激素治疗(如性别确认激素治疗)的儿童和青少年来说,未来的生育能力可能会受到负面影响。建议这些患者和家庭在接受治疗前进行生育力保存(FP)。青春期后患者的生育力保护与成人的生育力保护类似。然而,对于青春期前的儿童,可供选择的方案非常有限,在某些情况下仍处于试验阶段。这项工作必须继续下去,这样我们才能为儿童和青少年提供一个开放的未来,保护他们的生育能力。
{"title":"Fertility Preservation in Children and Adolescents: Where We Are and Where We Are Going.","authors":"Campbell Vogt, Neha R Malhotra","doi":"10.1007/s11934-024-01204-w","DOIUrl":"10.1007/s11934-024-01204-w","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review will describe current pediatric and adolescent fertility preservation methodologies and the ethical concerns surrounding these procedures, as well as highlight recent research that may pave the way for the development of new fertility preservation options.</p><p><strong>Recent findings: </strong>Research is ongoing to allow prepubertal patients, particularly those with testes, to be able to have biologic children in the future. Studies on sperm in vitro maturation highlight the importance of supporting the spermatogonial stem cell niche for the development of mature sperm. The live birth of a rhesus macaque from in vitro fertilization using prepubertal testicular tissue and in vivo matured sperm gives hope to future human births. For patients with ovaries, prior work has led to successful fertility but further research is underway to refine these techniques and optimize outcomes. Organoid scaffolds have shown promise when being used for in vitro oocyte maturation. For children and adolescents undergoing gonadotoxic treatment, such as chemotherapy, or hormonal treatment, such as gender-affirming hormone therapy, future fertility potential may be negatively impacted. It is recommended that fertility preservation (FP) be offered to these patients and families prior to undergoing treatment. Fertility preservation for postpubertal patients mimics that in adults. For prepubertal children, however, the options are limited and in some cases still experimental. It is essential that this work continues so that we may offer children and adolescents the right to an open future and preserve their fertility potential.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"133-140"},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacotherapy in Stress Urinary Incontinence; A Literature Review. 压力性尿失禁的药物治疗;文献综述。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 Epub Date: 2024-05-10 DOI: 10.1007/s11934-024-01205-9
Seyed Sajjad Tabei, Wesley Baas, Ayman Mahdy

Purpose of review: Stress urinary incontinence (SUI) is a commonly observed condition in females, as well as in males who have undergone prostatectomy. Despite the significant progress made in surgical techniques, pharmacotherapy has not yielded substantial outcomes within the clinical domain. This review aims to present a comprehensive overview of the existing pharmacotherapy options for stress urinary incontinence (SUI) and the emerging therapeutic targets in this field.

Recent findings: One meta-analysis demonstrated that α-adrenergic medications are more efficacious in improving rather than curing SUI symptoms. One trial showed reduced pad weight gain with PSD-503, a locally administered α-adrenergic receptor agonist. New data show that duloxetine's risk outweighs its benefits. One small-scale trial was found to support the use of locally administered estriol in improving subjective outcomes. Emerging targets include serotonin 5HT2C agonists, selective inhibitors of norepinephrine uptake, and myostatin inhibitors. Only one of the evaluated drugs, duloxetine, has been approved by some countries. Currently, trials are evaluating novel targets. Systemic adverse effects such as gastrointestinal upset with duloxetine and orthostatic hypotension with α-adrenoceptor agonists have hampered the efficacy of drugs used to treat SUI in women and men.

审查目的:压力性尿失禁(SUI)是女性和男性前列腺切除术后的常见病。尽管手术技术取得了重大进展,但药物治疗在临床领域并未取得实质性成果。本综述旨在全面概述压力性尿失禁(SUI)的现有药物治疗方案以及该领域新出现的治疗目标:一项荟萃分析表明,α-肾上腺素能药物在改善而非治愈 SUI 症状方面更为有效。一项试验显示,PSD-503(一种局部给药α肾上腺素能受体激动剂)可减少尿垫重量的增加。新数据显示度洛西汀的风险大于其益处。一项小规模试验支持使用局部给药的雌三醇来改善主观疗效。新出现的靶点包括血清素 5HT2C 激动剂、去甲肾上腺素摄取选择性抑制剂和肌生成抑制剂。在已评估的药物中,只有度洛西汀一种已获得一些国家的批准。目前,相关试验正在评估新的靶点。全身性不良反应,如度洛西汀会引起胃肠道不适,α肾上腺素受体激动剂会导致正性低血压,这些都阻碍了用于治疗女性和男性 SUI 的药物的疗效。
{"title":"Pharmacotherapy in Stress Urinary Incontinence; A Literature Review.","authors":"Seyed Sajjad Tabei, Wesley Baas, Ayman Mahdy","doi":"10.1007/s11934-024-01205-9","DOIUrl":"10.1007/s11934-024-01205-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>Stress urinary incontinence (SUI) is a commonly observed condition in females, as well as in males who have undergone prostatectomy. Despite the significant progress made in surgical techniques, pharmacotherapy has not yielded substantial outcomes within the clinical domain. This review aims to present a comprehensive overview of the existing pharmacotherapy options for stress urinary incontinence (SUI) and the emerging therapeutic targets in this field.</p><p><strong>Recent findings: </strong>One meta-analysis demonstrated that α-adrenergic medications are more efficacious in improving rather than curing SUI symptoms. One trial showed reduced pad weight gain with PSD-503, a locally administered α-adrenergic receptor agonist. New data show that duloxetine's risk outweighs its benefits. One small-scale trial was found to support the use of locally administered estriol in improving subjective outcomes. Emerging targets include serotonin 5HT<sub>2C</sub> agonists, selective inhibitors of norepinephrine uptake, and myostatin inhibitors. Only one of the evaluated drugs, duloxetine, has been approved by some countries. Currently, trials are evaluating novel targets. Systemic adverse effects such as gastrointestinal upset with duloxetine and orthostatic hypotension with α-adrenoceptor agonists have hampered the efficacy of drugs used to treat SUI in women and men.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"141-148"},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unlocking Peer Review: Elevating Scholarly Writing and Research Competence in Urology Residency. 开启同行评审:提高泌尿外科住院医生的学术写作和研究能力。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 Epub Date: 2024-06-05 DOI: 10.1007/s11934-024-01208-6
Kate Dwyer, George E Koch

Purpose of review: It is incumbent upon training programs to set the foundation for evidence-based practices and to create opportunities for trainees to develop into academic leaders. As dedicated resident research time and funding have declined in recent years, residency programs and the field at large will need to create new ways to incorporate scholarly activity into residency curricula.

Recent findings: Literature across specialties demonstrates barriers to resident involvement including lack of time, cost, and absent scholarly mentorship. Peer review stands as a ready-made solution that can be formalized into a collaborative relationship with journals. A formal relationship between professional societies, academic journals, and residencies can facilitate the use of peer review as a teaching tool for residency programs.

审查目的:培训项目有责任为循证实践奠定基础,并为学员创造机会发展成为学术带头人。近年来,由于住院医师专门的研究时间和经费都在减少,住院医师培训项目和整个领域都需要创造新的方法,将学术活动纳入住院医师培训课程:各专科的文献显示,住院医师参与的障碍包括缺乏时间、费用和缺乏学术指导。同行评议是一种现成的解决方案,可以与期刊建立正式的合作关系。专业学会、学术期刊和住院医师之间的正式关系可促进住院医师项目将同行评审作为一种教学工具。
{"title":"Unlocking Peer Review: Elevating Scholarly Writing and Research Competence in Urology Residency.","authors":"Kate Dwyer, George E Koch","doi":"10.1007/s11934-024-01208-6","DOIUrl":"10.1007/s11934-024-01208-6","url":null,"abstract":"<p><strong>Purpose of review: </strong>It is incumbent upon training programs to set the foundation for evidence-based practices and to create opportunities for trainees to develop into academic leaders. As dedicated resident research time and funding have declined in recent years, residency programs and the field at large will need to create new ways to incorporate scholarly activity into residency curricula.</p><p><strong>Recent findings: </strong>Literature across specialties demonstrates barriers to resident involvement including lack of time, cost, and absent scholarly mentorship. Peer review stands as a ready-made solution that can be formalized into a collaborative relationship with journals. A formal relationship between professional societies, academic journals, and residencies can facilitate the use of peer review as a teaching tool for residency programs.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"163-168"},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141247284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of the Devastated Bladder Outlet after Prostate CANCER Treatment. 前列腺癌治疗后膀胱出口受损的处理。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-07-01 Epub Date: 2024-05-16 DOI: 10.1007/s11934-024-01206-8
Francisco E Martins, Nicolaas Lumen, Henriette Veiby Holm

Purpose of review: Devastating complications of the bladder outlet resulting from prostate cancer treatments are relatively uncommon. However, the combination of the high incidence of prostate cancer and patient longevity after treatment have raised awareness of adverse outcomes deteriorating patients' quality of life. This narrative review discusses the diagnostic work-up and management options for bladder outlet obstruction resulting from prostate cancer treatments, including those that require urinary diversion.

Recent findings: The devastated bladder outlet can be a consequence of the treatment of benign conditions, but more frequently from complications of pelvic cancer treatments. Regardless of etiology, the initial treatment ladder involves endoluminal options such as dilation and direct vision internal urethrotomy, with or without intralesional injection of anti-fibrotic agents. If these conservative strategies fail, surgical reconstruction should be considered. Although surgical reconstruction provides the best prospect of durable success, reconstructive procedures are also associated with serious complications. In the worst circumstances, such as prior radiotherapy, failed reconstruction, devastated bladder outlet with end-stage bladders, or patient's severe comorbidities, reconstruction may neither be realistic nor justified. Urinary diversion with or without cystectomy may be the best option for these patients. Thorough patient counseling before treatment selection is of utmost importance. Outcomes and repercussions on quality of life vary extensively with management options. Meticulous preoperative diagnostic evaluation is paramount in selecting the right treatment strategy for each individual patient. The risk of bladder outlet obstruction, and its severest form, devastated bladder outlet, after treatment of prostate cancer is not negligible, especially following radiation. Management includes endoluminal treatment, open or robot-assisted laparoscopic reconstruction, and urinary diversion in the worst circumstances, with varying success rates.

审查目的:前列腺癌治疗导致的膀胱出口破坏性并发症相对来说并不常见。然而,前列腺癌的高发病率和患者治疗后的长寿使人们意识到不良后果会恶化患者的生活质量。这篇叙述性综述讨论了前列腺癌治疗导致的膀胱出口梗阻的诊断工作和处理方案,包括需要进行尿路改道的患者:膀胱出口受破坏可能是良性疾病治疗的结果,但更常见的是盆腔癌症治疗的并发症。无论病因如何,最初的治疗阶梯都包括腔内治疗,如扩张术和直视下尿道内切开术,同时或不同时进行抗纤维化药物的腔内注射。如果这些保守疗法无效,则应考虑手术重建。虽然手术重建最有可能取得持久的成功,但重建手术也会带来严重的并发症。在最糟糕的情况下,如之前接受过放射治疗、重建失败、膀胱出口受到破坏并出现终末期膀胱,或患者有严重的合并症,重建手术可能既不现实也不合理。对这些患者来说,最好的选择可能是进行或不进行膀胱切除术的尿路改道术。在选择治疗方法之前,对患者进行充分的咨询至关重要。治疗方案不同,其结果和对生活质量的影响也大不相同。缜密的术前诊断评估对于为每位患者选择正确的治疗策略至关重要。前列腺癌治疗后,尤其是放射治疗后,发生膀胱出口梗阻及其最严重形式的膀胱出口破坏的风险不容忽视。治疗方法包括腔内治疗、开腹或机器人辅助腹腔镜重建,以及在最糟糕的情况下进行尿流改道,但成功率各不相同。
{"title":"Management of the Devastated Bladder Outlet after Prostate CANCER Treatment.","authors":"Francisco E Martins, Nicolaas Lumen, Henriette Veiby Holm","doi":"10.1007/s11934-024-01206-8","DOIUrl":"10.1007/s11934-024-01206-8","url":null,"abstract":"<p><strong>Purpose of review: </strong>Devastating complications of the bladder outlet resulting from prostate cancer treatments are relatively uncommon. However, the combination of the high incidence of prostate cancer and patient longevity after treatment have raised awareness of adverse outcomes deteriorating patients' quality of life. This narrative review discusses the diagnostic work-up and management options for bladder outlet obstruction resulting from prostate cancer treatments, including those that require urinary diversion.</p><p><strong>Recent findings: </strong>The devastated bladder outlet can be a consequence of the treatment of benign conditions, but more frequently from complications of pelvic cancer treatments. Regardless of etiology, the initial treatment ladder involves endoluminal options such as dilation and direct vision internal urethrotomy, with or without intralesional injection of anti-fibrotic agents. If these conservative strategies fail, surgical reconstruction should be considered. Although surgical reconstruction provides the best prospect of durable success, reconstructive procedures are also associated with serious complications. In the worst circumstances, such as prior radiotherapy, failed reconstruction, devastated bladder outlet with end-stage bladders, or patient's severe comorbidities, reconstruction may neither be realistic nor justified. Urinary diversion with or without cystectomy may be the best option for these patients. Thorough patient counseling before treatment selection is of utmost importance. Outcomes and repercussions on quality of life vary extensively with management options. Meticulous preoperative diagnostic evaluation is paramount in selecting the right treatment strategy for each individual patient. The risk of bladder outlet obstruction, and its severest form, devastated bladder outlet, after treatment of prostate cancer is not negligible, especially following radiation. Management includes endoluminal treatment, open or robot-assisted laparoscopic reconstruction, and urinary diversion in the worst circumstances, with varying success rates.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"149-162"},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140944496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Urology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1